Ledger.Open graph →
SEC Form D · filed February 15, 2018

RevMAb Biosciences, Inc

Offering
$6.0M
Sold
$2.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SOUTH SAN FRANCISCO, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (4)

Yaohuang Ke · South San Francisco, CAExec · DirectorGeorge Lee · Fremont, CADirectorYaohuang Ke · South San Francisco, CAExec · DirectorGeorge Lee · San Diego, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗